Skip to main content

Advertisement

Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer

Fig. 6

Combination analysis of PD-L1 expression and TMB status as a biomarker set. a: Venn diagram showing the overlap of PD-L1 positive and TMB high subjects in EGFR-WT ADC patients, EGFR-mut ADC patients, as well as SQCC patients. B-E: Kaplan-Meier survival curves comparing ADC subjects (b), EGFR-WT ADC subjects (c), SQCC subjects (d) and WT-SQCC subjects (e) as stratified based on both PD-L1 TC expression and TMB status as indicated

Back to article page